VanEck Associates’s Crocs CROX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-50,459
Closed -$4.22M 1428
2025
Q3
$4.22M Buy
50,459
+2,427
+5% +$222K ﹤0.01% 815
2025
Q2
$4.87M Sell
48,032
-5,727
-11% -$584K 0.01% 746
2025
Q1
$5.71M Buy
53,759
+5,224
+11% +$541K 0.01% 658
2024
Q4
$5.32M Buy
48,535
+11,917
+33% +$1.39M 0.01% 675
2024
Q3
$4.81M Buy
36,618
+10,463
+40% +$1.43M 0.01% 657
2024
Q2
$3.82M Buy
+26,155
New +$3.67M 0.01% 678

Other funds holding CROX

VanEck Associates's CROX Position: Q4 2025 in Review

VanEck Associates sold out of Crocs (CROX) in Q4 2025, closing a stake of 50,459 shares — an estimated $4.22M sold.

VanEck Associates first reported a position in CROX in Q2 2024 and held it in 6 quarters. The position peaked at $5.71M in Q1 2025. 463 funds tracked by Wall St. Rank hold CROX as of Q4 2025.

  • VanEck Associates reported no remaining Crocs position as of Q4 2025 after selling out during the quarter.
  • VanEck Associates sold 50,459 Crocs shares in Q4 2025, an estimated $4.22M.
  • VanEck Associates first reported a position in Crocs in Q2 2024 and held it in 6 quarters.
  • VanEck Associates's Crocs position peaked at $5.71M in Q1 2025.
  • 463 funds tracked by Wall St. Rank held Crocs as of Q4 2025.

Based on VanEck Associates's 13F filing for Q4 2025, filed 13 Feb 2026.